Donelson Smith

Donelson Smith has a diverse work experience spanning several organizations and roles. Currently, they hold the position of Director at Sensei Bio, where they have been working since 2021. In this role, they have served as both the Director of Sensei Biotherapeutics and the Director of Synthetic Biology. Prior to joining Sensei Bio, Donelson was an Assistant Professor at the University of Washington from 2018 to 2021.

Before their time at the University of Washington, Donelson worked at the Howard Hughes Medical Institute from 2010 to 2021. During this period, they held the position of Research Specialist II and was the Senior Scientist in the Scott lab in the Department of Pharmacology at UW. In this role, they managed their own projects focused on signal transduction and the structural biology of molecular machines. Donelson also provided guidance and advice to post-doctoral fellows and graduate students.

Donelson's earlier experience includes being a Postdoctoral Fellow at the University of Washington from 2008 to 2010, where they conducted research on cellular signaling pathway organization. Donelson also worked as a Postdoctoral Fellow at OHSU from 2001 to 2008, studying A-kinase anchoring proteins. Additionally, they served as a Graduate Student at the University of North Carolina at Chapel Hill from 1995 to 2000, during which they worked as a Research Assistant, developing quantitative PCR protocols and studying brain GABAA receptor composition.

Overall, Donelson Smith's work experience showcases their expertise in signal transduction, molecular biology, and academia.

Donelson Smith attended the University of North Carolina at Chapel Hill from 1989 to 1993 and obtained a Bachelor of Science (BS) degree in Biology/Biological Sciences. From 1995 to 2000, they pursued further education at the same institution and earned a Doctor of Philosophy (Ph.D.) in Neurobiology and Neurosciences.